Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

A neurologist grapples with aducanumab

Anonymous
Conditions
January 26, 2022
Share
Tweet
Share

I have been following the controversy surrounding the approval of the new Alzheimer’s drug aducanumab with great interest.  Until a year and a half ago, I worked as a neurologist in an adult general neurology clinic.   Many of my patients had dementia.  While I thoroughly enjoyed seeing these patients and their family members, I often felt helpless when treating them.  When I left clinical practice to explore a non-clinical career in the pharmaceutical industry, I envisioned helping patients with neurological conditions by bringing much-needed drugs to market.  Drugs like aducanumab.

Aducanumab is the first disease-modifying drug approved for Alzheimer’s disease (AD) and the first AD medication to be approved in nearly two decades.  This should be exciting.  Instead, I find aducanumab’s approval both confusing and worrisome.  Simply stated, the drug has significant side effects, and it is unclear whether it has meaningful clinical benefit.  Despite the eleven-person neurological advisory board almost unanimously voting against approval, the FDA approved the drug this past summer via the accelerated approval process.  Subsequently, three of the neurologists on the advisory board quit, and there have been multiple editorials questioning the integrity of the FDA and its relationship with the pharmaceutical industry.

Within the pharmaceutical world, the approval of aducanumab is exciting.  It may pave the way for the approval of other AD drugs and drugs for other indications via the accelerated approval process.  At heart though, I am still a clinician and cannot help but imagine what I would do if I were still in practice.  Until there is more information about outcomes, I would not be inclined to prescribe it.  However, I suspect there would be great pressure from desperate patients and their families, and likely from the hospital system.

Closer to home, I contemplate aducanumab as it concerns my father-in-law, a retired cardiologist with mild AD.  Both my in-laws are declining.  They seem to be in the emergency department weekly, if not more often, and we are in the process of increasing their supervision via hiring a concierge physician and engaging a social worker to help them.  Recently, my father-in-law had multiple side effects from sequential trials of two acetylcholinesterase inhibitors discontinued due to intolerance.  I worry how he would fare if he had side effects from aducanumab, particularly symptomatic amyloid-related imaging abnormalities (ARIA), the anxiety this would cause, and the multiple MRIs and clinic follow-ups.

Last summer, my in-laws asked me about this pipeline drug they had heard about.  At that time, I told them the approval of aducanumab was unlikely and I did not revisit this with them once the surprise approval occurred.  More recently, I felt shame over keeping this information from them.  In my attempt to protect my in-laws, I deprived them of their autonomy.  At Thanksgiving, I came clean and told them about it, but fortunately, at least for now, my father-in-law’s neurologist does not plan on prescribing this drug.  I admit I am relieved.  I do not have to navigate the politics of aducanumab with my in-laws or with patients.  My former colleagues are not so lucky.

The author is an anonymous physician.

Image credit: Shutterstock.com

Prev

Setting boundaries and the power of saying no

January 26, 2022 Kevin 0
…
Next

Men's health is a catastrophe. Here's how we can help. [PODCAST]

January 26, 2022 Kevin 2
…

Tagged as: Neurology

Post navigation

< Previous Post
Setting boundaries and the power of saying no
Next Post >
Men's health is a catastrophe. Here's how we can help. [PODCAST]

ADVERTISEMENT

More by Anonymous

  • When the white coats become gatekeepers: How a quiet cartel strangles America’s health

    Anonymous
  • Graduating from medical school without family: a story of strength and survival

    Anonymous
  • Why young doctors in South Korea feel broken before they even begin

    Anonymous

Related Posts

  • Does the FDA approval of aducanumab mark the return of science-based medicine?

    Robert Trent
  • Can the Maternal CARE Act fail moms? 

    Sonal Patel, MD
  • Our patients matter, but at what cost to our families? 

    James A. Quinn, PA-C
  • For students with test stress, medical schools leave a void  

    Steve Blatt, MD
  • Opening schools? The devil is in the details. 

    Raghav Gupta, MD
  • Qualifying conditions for medical marijuana

    Patricia Frye

More in Conditions

  • Why medicine must stop worshipping burnout and start valuing humanity

    Sarah White, APRN
  • Why perinatal mental health is the top cause of maternal death in the U.S.

    Sheila Noon
  • A world without vaccines: What history teaches us about public health

    Drew Remignanti, MD, MPH
  • Unraveling the mystery behind one of the most dangerous pregnancy complications: preeclampsia

    Thomas McElrath, MD, PhD and Kara Rood, MD
  • How community paramedicine impacts Indigenous elders

    Noah Weinberg
  • Pain is more than physical: the story your body is trying to tell

    Katie Hatt, DO
  • Most Popular

  • Past Week

    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • Here’s what providers really need in a modern EHR

      Laura Kohlhagen, MD, MBA | Tech
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • How community paramedicine impacts Indigenous elders

      Noah Weinberg | Conditions
    • Why doctors are reclaiming control from burnout culture

      Maureen Gibbons, MD | Physician
    • How to speak the language of leadership to improve doctor wellness [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • Why tracking cognitive load could save doctors and patients

      Hiba Fatima Hamid | Education
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • Here’s what providers really need in a modern EHR

      Laura Kohlhagen, MD, MBA | Tech
    • What the world must learn from the life and death of Hind Rajab

      Saba Qaiser, RN | Conditions
    • How medical culture hides burnout in plain sight

      Marco Benítez | Conditions
  • Recent Posts

    • Why doctors are reclaiming control from burnout culture

      Maureen Gibbons, MD | Physician
    • Would The Pitts’ Dr. Robby Robinavitch welcome a new colleague? Yes. Especially if their initials were AI.

      Gabe Jones, MBA | Tech
    • Why medicine must stop worshipping burnout and start valuing humanity

      Sarah White, APRN | Conditions
    • Why screening for diseases you might have can backfire

      Andy Lazris, MD and Alan Roth, DO | Physician
    • How organizational culture drives top talent away [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why perinatal mental health is the top cause of maternal death in the U.S.

      Sheila Noon | Conditions

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • Here’s what providers really need in a modern EHR

      Laura Kohlhagen, MD, MBA | Tech
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • How community paramedicine impacts Indigenous elders

      Noah Weinberg | Conditions
    • Why doctors are reclaiming control from burnout culture

      Maureen Gibbons, MD | Physician
    • How to speak the language of leadership to improve doctor wellness [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • Why tracking cognitive load could save doctors and patients

      Hiba Fatima Hamid | Education
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • Here’s what providers really need in a modern EHR

      Laura Kohlhagen, MD, MBA | Tech
    • What the world must learn from the life and death of Hind Rajab

      Saba Qaiser, RN | Conditions
    • How medical culture hides burnout in plain sight

      Marco Benítez | Conditions
  • Recent Posts

    • Why doctors are reclaiming control from burnout culture

      Maureen Gibbons, MD | Physician
    • Would The Pitts’ Dr. Robby Robinavitch welcome a new colleague? Yes. Especially if their initials were AI.

      Gabe Jones, MBA | Tech
    • Why medicine must stop worshipping burnout and start valuing humanity

      Sarah White, APRN | Conditions
    • Why screening for diseases you might have can backfire

      Andy Lazris, MD and Alan Roth, DO | Physician
    • How organizational culture drives top talent away [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why perinatal mental health is the top cause of maternal death in the U.S.

      Sheila Noon | Conditions

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...